Grantham, Mayo, Van Otterloo & Co (GMO)’s Chimera Investment CIM Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CIM Stock Details CIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,067	Closed	-$225K	–	576
2017 Q4	$225K	Hold	4,067	–	–	﹤0.01%	546
2017 Q3	$231K	Sell	4,067 -100	-2%	-$5.68K	﹤0.01%	519
2017 Q2	$233K	Sell	4,167 -95,450	-96%	-$5.52M	﹤0.01%	524
2017 Q1	$6.03M	Buy	99,617 +18,886	+23%	+$1.05M	0.03%	220
2016 Q4	$4.12M	Buy	80,731 +20,459	+34%	+$1M	0.02%	257
2016 Q3	$2.88M	Buy	60,272 +26,672	+79%	+$1.31M	0.01%	301
2016 Q2	$1.58M	Buy	+33,600	New	+$1.48M	0.01%	392
2014 Q1	–	Sell	-11,874	Closed	-$552K	–	574
2013 Q4	$552K	Sell	11,874 -3,674	-24%	-$167K	﹤0.01%	531
2013 Q3	$709K	Sell	15,548 -1,458	-9%	-$64.8K	﹤0.01%	496
2013 Q2	$765K	Buy	+17,006	New	+$807K	﹤0.01%	490

Other funds holding CIM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $10.5B AUM 30.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WFI

West Family Investments Carlsbad, California $345M AUM 46.29% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s CIM Position: Q1 2018 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Chimera Investment (CIM) in Q1 2018, closing a stake of 4,067 shares — an estimated $225K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CIM in Q2 2013 and held it in 10 quarters. The position peaked at $6.03M in Q1 2017. 265 funds tracked by Wall St. Rank hold CIM as of Q1 2018.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Chimera Investment position as of Q1 2018 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,067 Chimera Investment shares in Q1 2018, an estimated $225K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Chimera Investment in Q2 2013 and held it in 10 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Chimera Investment position peaked at $6.03M in Q1 2017.
265 funds tracked by Wall St. Rank held Chimera Investment as of Q1 2018.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2018, filed 15 May 2018.